KalVista Pharmaceuticals申请提供3亿美元的混合货架

2024-07-12 05:08

KalVista Pharmaceuticals (NASDAQ:KALV) files prospectus to offer mixed shelf of up to $300M.
SEC Filing

More on KalVista Pharmaceticals

Bullish On KalVista Pharmaceuticals: Sebetralstat Nears Approval, Aiming For 2025 Launch
Seeking Alpha’s Quant Rating on KalVista Pharmaceticals
Historical earnings data for KalVista Pharmaceticals
Financial information for KalVista Pharmaceticals